WALVAX BIOTECHNOLO revenue breakdown overview

WALVAX BIOTECHNOLO revenue for the last year amounted to 4.11 B CNY, the most of which — 4.08 B CNY — came from its highest performing source at the moment, Autonomous Vaccine. The greatest contribution to the revenue figure was made by China — last year it brought WALVAX BIOTECHNOLO 3.83 B CNY, and the year before that — 4.80 B CNY.